Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 1, 1996, Pages 30-38

  Miller, B E ^a   Matherly, L H ^a,b   Lehotan, M ^a   Heppner, G H ^a  

^a Breast Cancer Program   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Drug resistance; Methotrexate; Tumor heterogeneity

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DIHYDROFOLATE REDUCTASE; METHOTREXATE;

ANIMAL; ARTICLE; C3H MOUSE; C57BL MOUSE; CANCER STEM CELL; DRUG RESISTANCE; EXPERIMENTAL NEOPLASM; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG RESISTANCE, NEOPLASM; MAMMARY NEOPLASMS, EXPERIMENTAL; METHOTREXATE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; TETRAHYDROFOLATE DEHYDROGENASE; TUMOR STEM CELLS;

EID: 0029677308     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 217: 998-1003, 1982.
2. Poste G, Grieg R. On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion Metastasis 2: 137-176, 1982.
3. Heppner GH. Tumor heterogeneity. Cancer Res 44: 2259-2265, 1984.
4. Miller BE, Miller FR, Leith J, Heppner GH. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res 40: 3977-3981, 1980.
5. Leith JT, Michelson S, Faulkner LE, Bliven SF. Growth properties of artificial heterogeneous human colon tumors. Cancer Res 47: 1045-1051, 1987.
6. Miller BE, Miller FR, Wilburn D, Heppner GH. Dominance of a mammary tumor subpopulation line in mixed, heterogeneous tumors. Cancer Res 48: 5747-4753, 1988.
7. Kerbel RS, Theodorescu D. Tumor cell supopulation interactions mediated by transforming growth factor α may contribute to clonal dominance of metastatically comapetent cells in primary tumors. In: Burger MM, Sordat B, Zingernagel RM, (eds). Cell to Cell Interaction, Basel: Karger, pp. 110-113, 1990.
8. Miller BE, Miller FR, Heppner GH. Tumor heterogeneity and drug sensitivity: interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate. Cancer Res 41: 4378-4381, 1981.
9. Tofilon PJ, Buckley N, Deen PF. Effect of cell-cell interactions on drug sensitivity and growth of drug-sensitive and -resistant tumor cells in spheroids. Science 226:, 862-864, 1984.
10. Miller BE, Miller FR, Heppner GH. Therapeutic perturbations of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Cancer Res 49: 3747-3753, 1989.
11. Graham ML, Smith JA, Jewett PB, Horwitz KB. Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry. Cancer Res 52: 593-602, 1992.
12. Poste G, Tzeng J, Doll J, Grieg R, Rieman D, Zeidman I. Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci (USA) 79: 6574-6578, 1982.
13. Miner KM, Kawaguchi T, Uba GW, Nicolson GL. Clonal drift of cell surface, melanogenesis, and experimental metastatic properties of in vivo selected, brain meninges-colonizing murine B16 melanoma. Cancer Res 42: 4631-4636, 1982.
14. Miller BE, Miller FR, Wilburn D, Heppner GH. Analysis of tumor cell composition of tumors composed of paired mixtures of mammary tumor cell lines. Br J Cancer 56:, 561-569, 1987.
15. Itaya T, Judde J, Hunt B, Frost P. Genotypic and phenotypic evidence of clonal interactions in murine tumor cells. J Natl Cancer Inst 81: 664-668, 1989.
16. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38: 3174-3181, 1978.
17. Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mouse mammary tumor. Cancer Res 38: 3758-3763, 1978.
18. Miller BE, Machemer T, Lehotan M, Heppner GH. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors. Cancer Res 51: 4378-4387, 1991.
19. Fry DW, Yalowich JC, Goldman ID. Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem 257: 1890-1896, 1982.
20. Matherly LH, Czajkowski CA, Angeles SM. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res 51: 3420-3426, 1991.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1957.
22. Bertino JR, Dolnick BJ, Berenson J, Scheer DI, Kamen BA. Cellular mechanisms of resistance to methotrexate. In: Sartorelli SC, Lazo JS, Bertino JR (eds), Molecular Actions and Targets for Cancer Chemotherapeutic Agents, New York: Academic Press, pp. 385-397, 1981.
23. Matherly LH, Seither RL, Goldman ID. The basis of antifolate cytotoxicity, selectivity, and metabolic transformations: effects on utilization of endogenous and exogenous folate cofactors. In: Powis G, (ed), Anticancer Drugs: Antimetabolite Metabolism and Natural Anticancer Agents, Oxford: Pergammon Press, pp. 139-177, 1994.
24. Pizzorno G, Chang YM, McGuire JJ, Bertino JR. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug. Cancer Res 49: 5275-5280, 1989.
25. McCloskey DE, McGuire JJ, Russell CA, Rowan BG, Bertino JR, Pizzorno G, Mini R. Decreased folyl-polyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. J Biol Chem 266: 6181-6187, 1991.
26. Jackson RC, Niethammer D. Acquired methotrexate resistance in lympnoblasts resulting from altered kinetic properties of dihydrofolate reductase. Eur J Cancer 13: 567-575, 1977.
27. Flintoff WF, Essani K. Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry 19: 4321-4327, 1980.
28. Goldie JH, Krystal G, Hartley D, Gudauskas G, Dedhar S. A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178 gamma cells. Eur J Cancer 16: 1539-1546, 1980.
29. Haber DA, Beverly SM, Kiely ML, Schimke RT. Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J Biol Chem 256: 9501-9510, 1981.